Cardax Pharma

United States
Bend, Oregon, United States, 96822

Company profile

Cardax Pharma company profile

Cardax Pharmaceuticals develops proprietary small molecule therapies for large unmet medical needs where oxidative stress and inflammation play important causative roles—including dyslipidemia, metabolic disease, arthritis, cardiovascular disease, hepatitis, macular degeneration, and many others. Most anti-inflammatory drugs have significant safety and side effect issues that limit their utility. In contrast, the company’s proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers robust efficacy combined with exceptional safety, oral bioavailability, and tissue selectivity.

Business identity

Contact email
[email protected]
Phone number
(808) 457-1400
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2006-01-01, Year

Headquarters

Postal code
96822
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
9
Total equity funding
$4.8M
Last funding
Post IPO Equity / $2.8M / 2017-04-28
Last equity funding
Post IPO Equity / $2.8M
Investors
1
Founders
1
Exited on
2015-06-30

Founders and investors

Founders

David G. Watumull

Investors

Advantage Capital